{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T14:56:43Z","timestamp":1786460203870,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This scoping review aims to identify and describe the physical sequelae experienced by adolescents with perinatally acquired HIV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Perinatally acquired HIV is a prevalent condition affecting adolescents. It results in neurocognitive dysfunction and mental health challenges. Data show that some of the physical challenges facing this population include stunted growth and delayed puberty; however, other physical challenges remain largely unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Inclusion criteria:<\/jats:title>\n                    <jats:p>This review will consider studies that include adolescents aged 10 to 19\u200ayears, with perinatally (vertically) acquired HIV. Adolescents from any geographic area, of any ethnicity or socioeconomic background will be considered. The concepts included will be all physical sequelae of perinatally acquired HIV. Studies of any research design, including quantitative, qualitative, and mixed methods, as well as systematic reviews, will be considered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This review will utilize a three-step search strategy. There will be an initial search of MEDLINE (PubMed), followed by a full search of MEDLINE (PubMed), PEDro, CINAHL (EBSCO), Scopus (Elsevier), ScienceDirect (Elsevier), and Google Scholar. Gray literature will be searched using CDC Stacks and OpenGrey. Lastly, the reference lists of all articles will be checked for additional studies. Titles and abstracts will be screened by two independent reviewers against the inclusion criteria, and a third reviewer will resolve any discrepancies. Results will be charted on a data extraction tool and presented with a table, diagrammatic representation, and a descriptive narrative.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.11124\/jbies-20-00338","type":"journal-article","created":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T21:00:38Z","timestamp":1622408438000},"page":"3149-3154","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Physical sequelae of growing into adolescence with perinatally acquired HIV: a scoping review protocol"],"prefix":"10.11124","volume":"19","author":[{"given":"Nicolette","family":"Comley-White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Potterton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Ntsiea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,11]]},"reference":[{"issue":"(10036)","key":"R2-20250613","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/S0140-6736(16)00579-1","article-title":"Our future: a Lancet commission on adolescent health and wellbeing","volume":"387","author":"Patton","year":"2016","journal-title":"Lancet"},{"issue":"(1)","key":"R4-20250613","doi-asserted-by":"crossref","first-page":"18555","DOI":"10.7448\/IAS.16.1.18555","article-title":"The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents","volume":"16","author":"Sohn","year":"2013","journal-title":"J Int AIDS Soc"},{"issue":"(2)","key":"R5-20250613","first-page":"234","article-title":"Perinatally acquired HIV infection: long-term neuropsychological consequences and challenges ahead","volume":"21","author":"Smith","year":"2015","journal-title":"J Pediatr Neuropsychol"},{"issue":"(1)","key":"R6-20250613","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev.med.050108.151127","article-title":"Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection","volume":"61","author":"Hazra","year":"2010","journal-title":"Annu Rev Med"},{"issue":"(3)","key":"R7-20250613","first-page":"511","article-title":"Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models","volume":"108","author":"Rice","year":"2000","journal-title":"Environ Health Perspect"},{"key":"R8-20250613","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainres.2011.05.015","article-title":"Breaking down the barrier: the effects of HIV-1 on the blood\u2013brain barrier","volume":"1399","author":"Strazza","year":"2011","journal-title":"Brain Res"},{"issue":"(6)","key":"R9-20250613","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/COH.0000000000000110","article-title":"The brain and HAART: collaborative and combative connections","volume":"9","author":"Meeker","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"issue":"(2)","key":"R10-20250613","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40263-013-0132-4","article-title":"Neurological and psychiatric adverse effects of antiretroviral drugs","volume":"28","author":"Abers","year":"2014","journal-title":"CNS Drugs"},{"issue":"(1)","key":"R11-20250613","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.REO.0000000000000150","article-title":"Interventions addressing neurodevelopmental delay in young children infected with and exposed to HIV: a scoping review","volume":"37","author":"Strehlau","year":"2019","journal-title":"Rehabil Oncol"},{"issue":"(5)","key":"R12-20250613","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/rmv.1793","article-title":"Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy: HIV-associated neurologic disease in children","volume":"24","author":"Crowell","year":"2014","journal-title":"Rev Med Virol"},{"issue":"(4)","key":"R13-20250613","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/09540121.2013.841828","article-title":"The neurodevelopment of HIV-infected infants on HAART compared to HIV-exposed but uninfected infants","volume":"26","author":"Whitehead","year":"2014","journal-title":"AIDS Care"},{"key":"R14-20250613","first-page":"35","article-title":"Cognitive impairment in patients with AIDS- prevalence and severity","volume":"7","author":"Watkins","year":"2015","journal-title":"HIV AIDS (Auckl)"},{"issue":"(2)","key":"R15-20250613","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/11597770-000000000-00000","article-title":"HIV-associated neurological disorders: a guide to pharmacotherapy","volume":"26","author":"Tan","year":"2012","journal-title":"CNS Drugs"},{"issue":"(1)","key":"R16-20250613","doi-asserted-by":"crossref","first-page":"18603","DOI":"10.7448\/IAS.16.1.18603","article-title":"Neurodevelopment in perinatally HIV-infected children: a concern for adolescence","volume":"16","author":"Laughton","year":"2013","journal-title":"J Int AIDS Soc"},{"issue":"(3)","key":"R17-20250613","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/09540121.2016.1234677","article-title":"Young adults perinatally infected with HIV perform more poorly on measures of executive functioning and motor speed than ethnically matched healthy controls","volume":"29","author":"Willen","year":"2017","journal-title":"AIDS Care"},{"key":"R18-20250613","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1473-3099(13)70363-3","article-title":"Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges","volume":"14","author":"Lowenthal","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"(11)","key":"R19-20250613","doi-asserted-by":"crossref","first-page":"e25412","DOI":"10.1002\/jia2.25412","article-title":"Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration","volume":"22","author":"Jesson","year":"2019","journal-title":"J Int AIDS Soc"},{"issue":"(2)","key":"R20-20250613","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/INF.0000000000000961","article-title":"Final height and associated factors in perinatally HIV-infected Asian adolescents","volume":"35","author":"Bunupuradah","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"(9)","key":"R21-20250613","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/QAD.0000000000001486","article-title":"Delay in sexual maturation in perinatally HIV-infected youths is mediated by poor growth","volume":"31","author":"Bellavia","year":"2017","journal-title":"AIDS"},{"issue":"(3)","key":"R22-20250613","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/COH.0000000000000450","article-title":"Growth and pubertal development in HIV-infected adolescents","volume":"13","author":"Williams","year":"2018","journal-title":"Curr Opin HIV AIDS"},{"issue":"(9)","key":"R23-20250613","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/INF.0000000000001574","article-title":"Child growth according to maternal and child HIV status in Zimbabwe","volume":"36","author":"Omoni","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"(1)","key":"R24-20250613","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF03345686","article-title":"Growth and puberty in children with HIV infection","volume":"32","author":"Majaliwa","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"R25-20250613","article-title":"Chapter 11: scoping reviews","author":"Peters","year":"2020","journal-title":"JBI Manual for Evidence Synthesis [internet]"},{"issue":"(7)","key":"R29-20250613","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"(7)","key":"R30-20250613","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1377\/hlthaff.2018.05391","article-title":"Twenty years of antiretroviral therapy for people living with HIV: global costs, health achievements, economic benefits","volume":"38","author":"Forsythe","year":"2019","journal-title":"Health Aff"},{"issue":"(7)","key":"R31-20250613","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"}],"container-title":["JBI Evidence Synthesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-20-00338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:35:18Z","timestamp":1786451718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-20-00338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":26,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.11124\/jbies-20-00338","relation":{},"ISSN":["2689-8381"],"issn-type":[{"value":"2689-8381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,28]]}}}